This list is based on the watchlists of people on Stock Events who follow BIOG.LSE. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.
Show more...
FAQ
What is Biotech Growth Trust stock price today?▼
The current price of BIOG.LSE is GBX1,384.00 GBX — it has increased by +1.47% in the past 24 hours. Watch Biotech Growth Trust stock price performance more closely on the chart.
What is Biotech Growth Trust stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Biotech Growth Trust stocks are traded under the ticker BIOG.LSE.
Is Biotech Growth Trust stock price growing?▼
BIOG.LSE stock has risen by +6.63% compared to the previous week, the month change is a +9.84% rise, over the last year Biotech Growth Trust has showed a +91.16% increase.
Does Biotech Growth Trust pay dividends?▼
Yes, BIOG.LSE dividends are paid annual. The last dividend per share was 0.2 GBX. As of today, Dividend Yield (FWD)% is 0%.
In which sector is Biotech Growth Trust located?▼
Biotech Growth Trust operates in the Finance & Payments sector.
When did Biotech Growth Trust complete a stock split?▼
Biotech Growth Trust has not had any recent stock splits.
Where is Biotech Growth Trust headquartered?▼
Biotech Growth Trust is headquartered in New York, United Kingdom.